E-LIB Suche - Ergebnisse für: Fraser, Graeme A.M.

1

Fractionated Stereotactic Radiation for Central Nervous Sys..:

Schep, Daniel G. ; Mir, Taskia ; Fraser, Graeme A. M..
Current Oncology. 30 (2023) 9 - p. 8602-8611 , 2023

2

A Prospective Economic Analysis of Early Outcome Data From ..:

Cheung, Matthew C. ; Mittmann, Nicole ; Owen, Carolyn...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) 11 - p. 766-774 , 2021

Link: https://doi.org/10.1016/..

3

Final 5-year findings from the phase 3 HELIOS study of ibru..:

Fraser, Graeme A.M. ; Chanan-Khan, Asher ; Demirkan, Fatih...
Leukemia & Lymphoma. 61 (2020) 13 - p. 3188-3197 , 2020

Link: https://doi.org/10.1080/..

4

Cytomegalovirus prophylaxis and treatment after hematopoiet..:

Fraser, Graeme A.M. ; Walker, Irwin I.
Biology of Blood and Marrow Transplantation. 10 (2004) 5 - p. 287-297 , 2004

Link: https://doi.org/10.1016/..

5

Persistent hematopoietic polyclonality after lentivirus-med..:

Saleh, Amr H. ; Rothe, Michael ; Barber, Dwayne L....
Molecular Therapy - Methods & Clinical Development. 28 (2023) - p. 262-271 , 2023

Link: https://doi.org/10.1016/..

6

Lentivirus-mediated gene therapy for Fabry disease:

Khan, Aneal ; Barber, Dwayne L. ; Huang, Ju...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

7

Randomized Controlled Trial of Neurokinin 3 Receptor Antago..:

Fraser, Graeme L ; Obermayer-Pietsch, Barbara ; Laven, Joop...
The Journal of Clinical Endocrinology & Metabolism. 106 (2021) 9 - p. e3519-e3532 , 2021

Link: https://doi.org/10.1210/..

8

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy i..:

Kipps, Thomas J. ; Fraser, Graeme ; Coutre, Steven E....
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 11 - p. 715-722.e6 , 2019

Link: https://doi.org/10.1016/..

9

Safety Analysis of Four Randomized Controlled Studies of Ib..:

O'Brien, Susan ; Hillmen, Peter ; Coutre, Steven...
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) 10 - p. 648-657.e15 , 2018

Link: https://doi.org/10.1016/..

10

N-Thiazolylamide-based free fatty-acid 2 receptor agonists:..:

Hoveyda, Hamid R. ; Fraser, Graeme L. ; Zoute, Ludivine...
Bioorganic & Medicinal Chemistry. 26 (2018) 18 - p. 5169-5180 , 2018

Link: https://doi.org/10.1016/..

11

Incidence of and risk factors for major haemorrhage in pati..:

Brown, Jennifer R. ; Moslehi, Javid ; Ewer, Michael S....
British Journal of Haematology. 184 (2018) 4 - p. 558-569 , 2018

Link: https://doi.org/10.1111/..

12

Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggr..:

Buckstein, Rena ; Fraser, Graeme ; Cheung, Matthew...
Clinical Lymphoma Myeloma and Leukemia. 16 (2016) 1 - p. 18-28.e4 , 2016

Link: https://doi.org/10.1016/..

13

The NK3 Receptor Antagonist ESN364 Interrupts Pulsatile LH ..:

Fraser, Graeme L. ; Hoveyda, Hamid R. ; Clarke, Iain J....
Endocrinology. 156 (2015) 11 - p. 4214-4225 , 2015

Link: https://doi.org/10.1210/..

14

Corrigendum to "Discovery of 3-aryl-5-acylpiperazinyl-pyraz..:

Hoveyda, Hamid R. ; Roy, Marie-Odile ; Blanc, Sebastien...
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 23 - p. 7228 , 2011

Link: https://doi.org/10.1016/..

15

Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagoni..:

Hoveyda, Hamid R. ; Roy, Marie-Odile ; Blanc, Sebastien...
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 7 - p. 1991-1996 , 2011

Link: https://doi.org/10.1016/..